Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Hospital and Surgical Privileges for Doctors of Podiatric Medicine.

Rogers LC, Stavosky JW.

J Am Podiatr Med Assoc. 2019;109(S1):1-4. doi: 10.7547/8750-7315-109.S1.1.

PMID:
31760757
2.

Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials.

Galiano R, Snyder R, Mayer P, Rogers LC, Alvarez O; Sanuwave Trial Investigators.

J Wound Care. 2019 Jun 2;28(6):383-395. doi: 10.12968/jowc.2019.28.6.383.

PMID:
31166864
3.

Diabetic foot ulcer treatment with focused shockwave therapy: two multicentre, prospective, controlled, double-blinded, randomised phase III clinical trials.

Snyder R, Galiano R, Mayer P, Rogers LC, Alvarez O; Sanuwave Trial Investigators.

J Wound Care. 2018 Dec 2;27(12):822-836. doi: 10.12968/jowc.2018.27.12.822.

PMID:
30557108
4.

Strain-specific effect on biphasic DNA binding by HIV-1 integrase.

Hill KJ, Rogers LC, Njenda DT, Burke DH, Sarafianos SG, Sönnerborg A, Neogi U, Singh K.

AIDS. 2019 Mar 1;33(3):588-592. doi: 10.1097/QAD.0000000000002078.

PMID:
30475264
5.

Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy.

Rogers LC, Davis RR, Said N, Hollis T, Daniel LW.

Redox Biol. 2018 May;15:380-386. doi: 10.1016/j.redox.2018.01.002. Epub 2018 Jan 4.

6.

Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.

Neogi U, Singh K, Aralaguppe SG, Rogers LC, Njenda DT, Sarafianos SG, Hejdeman B, Sönnerborg A.

AIDS. 2018 Feb 20;32(4):469-476. doi: 10.1097/QAD.0000000000001726.

7.

Endogenous, regulatory cysteine sulfenylation of ERK kinases in response to proliferative signals.

Keyes JD, Parsonage D, Yammani RD, Rogers LC, Kesty C, Furdui CM, Nelson KJ, Poole LB.

Free Radic Biol Med. 2017 Nov;112:534-543. doi: 10.1016/j.freeradbiomed.2017.08.018. Epub 2017 Aug 24.

8.

The SAMHD1 dNTP Triphosphohydrolase Is Controlled by a Redox Switch.

Mauney CH, Rogers LC, Harris RS, Daniel LW, Devarie-Baez NO, Wu H, Furdui CM, Poole LB, Perrino FW, Hollis T.

Antioxid Redox Signal. 2017 Dec 1;27(16):1317-1331. doi: 10.1089/ars.2016.6888. Epub 2017 Apr 18.

9.

The Use of a Sea Salt-based Spray for Diabetic Foot Ulcers: A Novel Concept.

Pougatsch DA, Rader A, Rogers LC.

Wounds. 2017 Feb;29(2):E5-E9.

10.

Accurate Point-of-Care Detection of Ruptured Fetal Membranes: Improved Diagnostic Performance Characteristics with a Monoclonal/Polyclonal Immunoassay.

Rogers LC, Scott L, Block JE.

Clin Med Insights Reprod Health. 2016 May 9;10:15-8. doi: 10.4137/CMRH.S38386. eCollection 2016.

11.

Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.

Neogi U, Häggblom A, Singh K, Rogers LC, Rao SD, Amogne W, Schülter E, Zazzi M, Arnold E, Sarafianos SG, Sönnerborg A.

J Antimicrob Chemother. 2016 Feb;71(2):367-71. doi: 10.1093/jac/dkv359. Epub 2015 Oct 30.

12.
13.

Abrupt CMS Decision May Threaten Hundreds of Thousands of Wound Care Patients with Potential Limb Loss.

Bell D, Snyder RJ, Rogers LC.

Ostomy Wound Manage. 2015 Jun;61(6):14. No abstract available.

14.

Credentialing guidelines for doctors of podiatric medicine supervising hyperbaric oxygen therapy a position paper.

Rogers LC, DellaCorte MP, Stavosky JW, Millington JT, Capotorto JV.

J Am Podiatr Med Assoc. 2015 Jul;105(4):367-70. doi: 10.7547/14-133.1. Epub 2015 Feb 3. Review.

PMID:
25649892
15.

The management of diabetic foot ulcers through optimal off-loading: building consensus guidelines and practical recommendations to improve outcomes.

Snyder RJ, Frykberg RG, Rogers LC, Applewhite AJ, Bell D, Bohn G, Fife CE, Jensen J, Wilcox J.

J Am Podiatr Med Assoc. 2014 Nov;104(6):555-67. doi: 10.7547/8750-7315-104.6.555.

PMID:
25514266
16.

Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling.

Klomsiri C, Rogers LC, Soito L, McCauley AK, King SB, Nelson KJ, Poole LB, Daniel LW.

Free Radic Biol Med. 2014 Jun;71:49-60. doi: 10.1016/j.freeradbiomed.2014.03.017. Epub 2014 Mar 21.

17.

The Charcot foot.

Rogers LC, Frykberg RG.

Med Clin North Am. 2013 Sep;97(5):847-56. doi: 10.1016/j.mcna.2013.04.003. Epub 2013 May 16. Review.

PMID:
23992896
18.

Establishing benchmarks and metrics for disruptive technologies, inappropriate and obsolete tests in the clinical laboratory.

Kiechle FL, Arcenas RC, Rogers LC.

Clin Chim Acta. 2014 Jan 1;427:131-6. doi: 10.1016/j.cca.2013.05.024. Epub 2013 May 31. Review.

PMID:
23732401
19.

A unified mechanism for abiotic adenine and purine synthesis in formamide.

Hudson JS, Eberle JF, Vachhani RH, Rogers LC, Wade JH, Krishnamurthy R, Springsteen G.

Angew Chem Int Ed Engl. 2012 May 21;51(21):5134-7. doi: 10.1002/anie.201108907. Epub 2012 Apr 5. No abstract available.

PMID:
22488748
20.

Competitive bidding for negative pressure wound therapy: what will it mean to you?

Rogers LC, Andros G.

Ostomy Wound Manage. 2011 Dec;57(12):48. No abstract available.

PMID:
22263255
21.

The Charcot foot in diabetes.

Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L.

J Am Podiatr Med Assoc. 2011 Sep-Oct;101(5):437-46. Review.

PMID:
21957276
22.

External fixation techniques for plastic and reconstructive surgery of the diabetic foot.

Belczyk RJ, Rogers LC, Andros G, Wukich DK, Burns PR.

Clin Podiatr Med Surg. 2011 Aug;28(4):649-60. doi: 10.1016/j.cpm.2011.07.001. Review.

PMID:
21944398
23.

The Charcot foot in diabetes.

Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L.

Diabetes Care. 2011 Sep;34(9):2123-9. doi: 10.2337/dc11-0844.

24.

Human digit partially consumed by a canine during sleep in a patient with neuropathy and diabetes.

Rogers LC, Bevilacqua NJ.

J Am Podiatr Med Assoc. 2011 May-Jun;101(3):275-6.

PMID:
21622641
25.
26.

Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells.

Saunders JA, Rogers LC, Klomsiri C, Poole LB, Daniel LW.

Free Radic Biol Med. 2010 Dec 15;49(12):2058-67. doi: 10.1016/j.freeradbiomed.2010.10.663. Epub 2010 Oct 8.

27.

Toe and flow: essential components and structure of the amputation prevention team.

Rogers LC, Andros G, Caporusso J, Harkless LB, Mills JL Sr, Armstrong DG.

J Am Podiatr Med Assoc. 2010 Sep-Oct;100(5):342-8.

PMID:
20847347
28.

Toe and flow: essential components and structure of the amputation prevention team.

Rogers LC, Andros G, Caporusso J, Harkless LB, Mills JL Sr, Armstrong DG.

J Vasc Surg. 2010 Sep;52(3 Suppl):23S-27S. doi: 10.1016/j.jvs.2010.06.004. Review.

29.

Digital planimetry results in more accurate wound measurements: a comparison to standard ruler measurements.

Rogers LC, Bevilacqua NJ, Armstrong DG, Andros G.

J Diabetes Sci Technol. 2010 Jul 1;4(4):799-802.

30.

Use of dimedone-based chemical probes for sulfenic acid detection methods to visualize and identify labeled proteins.

Nelson KJ, Klomsiri C, Codreanu SG, Soito L, Liebler DC, Rogers LC, Daniel LW, Poole LB.

Methods Enzymol. 2010;473:95-115. doi: 10.1016/S0076-6879(10)73004-4. Review.

31.

Organized programs to prevent lower-extremity amputations.

Rogers LC, Bevilacqua NJ.

J Am Podiatr Med Assoc. 2010 Mar-Apr;100(2):101-4.

PMID:
20237360
32.

Gastrocnemius recession as an alternative to tendoAchillis lengthening for relief of forefoot pressure in a patient with peripheral neuropathy: a case report and description of a technical modification.

Greenhagen RM, Johnson AR, Peterson MC, Rogers LC, Bevilacqua NJ.

J Foot Ankle Surg. 2010 Mar-Apr;49(2):159.e9-13. doi: 10.1053/j.jfas.2009.07.002. Epub 2010 Feb 4.

PMID:
20137982
33.

Accuracy in identifying podiatric surgeries.

Budny AM, Rogers LC.

Chest. 2010 Jan;137(1):242-3; author reply 243. doi: 10.1378/chest.09-1869. No abstract available.

PMID:
20051421
34.

Can we predict outcome of surgical reconstruction of Charcot neuroarthropathy by dynamic plantar pressure assessment?--A proof of concept study.

Najafi B, Crews RT, Armstrong DG, Rogers LC, Aminian K, Wrobel J.

Gait Posture. 2010 Jan;31(1):87-92. doi: 10.1016/j.gaitpost.2009.09.003.

PMID:
19836956
35.

Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study.

Sunderji S, Gaziano E, Wothe D, Rogers LC, Sibai B, Karumanchi SA, Hodges-Savola C.

Am J Obstet Gynecol. 2010 Jan;202(1):40.e1-7. doi: 10.1016/j.ajog.2009.07.025. Epub 2009 Sep 17.

PMID:
19762001
36.

Pregabalin for painful diabetic peripheral neuropathy.

Rogers LC, Armstrong DG.

Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):14-5. doi: 10.1038/ncpendmet1019. Epub 2008 Nov 18. No abstract available.

PMID:
19015648
37.

Clinical evaluation of a wound measurement and documentation system.

Romanelli M, Dini V, Rogers LC, Hammond CE, Nixon MA.

Wounds. 2008 Sep;20(9):258-64.

PMID:
25941848
38.

Neuropathy in diabetes: not a knee-jerk diagnosis.

Rogers LC, Bevilacqua NJ, Malik RA, Armstrong DG.

J Am Podiatr Med Assoc. 2008 Jul-Aug;98(4):322-5.

PMID:
18685055
39.

Re: Alcohol induced neuroarthropathy in the foot--a case series and review of literature.

Rogers LC.

J Foot Ankle Surg. 2008 Jul-Aug;47(4):372-3; author reply 373. doi: 10.1053/j.jfas.2008.03.001. No abstract available.

PMID:
18590906
40.

Novel translocation responses of cytosolic phospholipase A2alpha fluorescent proteins.

Wooten RE, Willingham MC, Daniel LW, Leslie CC, Rogers LC, Sergeant S, O'Flaherty JT.

Biochim Biophys Acta. 2008 Aug;1783(8):1544-50. doi: 10.1016/j.bbamcr.2008.03.008. Epub 2008 Mar 21.

41.

Diabetic foot surgery: classifying patients to predict complications.

Bevilacqua NJ, Rogers LC, Armstrong DG.

Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S81-3. doi: 10.1002/dmrr.858. Review.

PMID:
18357584
42.

The right to bear legs--an amendment to healthcare: how preventing amputations can save billions for the US Health-care System.

Rogers LC, Lavery LA, Armstrong DG.

J Am Podiatr Med Assoc. 2008 Mar-Apr;98(2):166-8. No abstract available.

PMID:
18348977
43.

Charcot's arthropathy in a patient with HIV-associated neuropathy.

Rogers LC, Bevilacqua NJ, Dellacorte MP, Francis K, Armstrong DG.

J Am Podiatr Med Assoc. 2008 Mar-Apr;98(2):153-5.

PMID:
18347127
44.

Imaging of the Charcot foot.

Rogers LC, Bevilacqua NJ.

Clin Podiatr Med Surg. 2008 Apr;25(2):263-74, vii. doi: 10.1016/j.cpm.2008.01.002. Review.

PMID:
18346593
45.

A technique to protect external fixation devices.

Bevilacqua NJ, Dankert JP, Rogers LC, Armstrong DG.

J Foot Ankle Surg. 2008 Mar-Apr;47(2):172-4. doi: 10.1053/j.jfas.2007.12.003.

PMID:
18312927
46.

Restoration and preservation of first metatarsal length using the distraction scarf osteotomy.

Bevilacqua NJ, Rogers LC, Wrobel JS, Shechter DZ.

J Foot Ankle Surg. 2008 Mar-Apr;47(2):96-102. doi: 10.1053/j.jfas.2007.11.001.

PMID:
18312916
47.

The use of marrow-derived stem cells to accelerate healing in chronic wounds.

Rogers LC, Bevilacqua NJ, Armstrong DG.

Int Wound J. 2008 Mar;5(1):20-5. doi: 10.1111/j.1742-481X.2007.00349.x. Epub 2008 Jan 3.

PMID:
18179555
48.

The narrowed forefoot at 1 year: an advanced approach for wound closure after central ray amputations.

Bevilacqua NJ, Rogers LC, DellaCorte MP, Armstrong DG.

Clin Podiatr Med Surg. 2008 Jan;25(1):127-33, viii. doi: 10.1016/j.cpm.2007.10.002.

PMID:
18165117
49.

Surgical management of Charcot midfoot deformities.

Bevilacqua NJ, Rogers LC.

Clin Podiatr Med Surg. 2008 Jan;25(1):81-94, vii. doi: 10.1016/j.cpm.2007.10.007. Review.

PMID:
18165114
50.

The diagnosis of Charcot foot.

Rogers LC, Bevilacqua NJ.

Clin Podiatr Med Surg. 2008 Jan;25(1):43-51, vi. doi: 10.1016/j.cpm.2007.10.006. Review.

PMID:
18165110

Supplemental Content

Loading ...
Support Center